Top Markets
#1 0G 0G +11.60%
#2 Siacoin Siacoin +9.25%
#3 Cash Cat Cash Cat +8.48%
#4 Arbitrum Arbitrum +7.02%
#5 MarsCoin MarsCoin +6.90%
#6 Asteroid Shiba Asteroid Shiba +6.90%
#7 Seeker Seeker +6.12%
#8 Metis Metis +6.04%
#9 Useless Coin Useless Coin +5.01%
#10 Optimism Optimism +4.77%
Coin of the day
0G 0G
Pengaturan
Bahasa
BAHASA INDONESIA
Mata uang
USD
Tema
Fennec Pharmaceuticals Inc. Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals Inc.

FENC
Peringkat dalam Saham #14209
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical firm. Its leading... Fennec Pharmaceuticals Inc. operates as a biopharmaceutical firm. Its leading investigational drug in clinical development is PEDMARK, a specialized formulation of sodium thiosulfate. This treatment is designed to shield young cancer patients from hearing damage (ototoxicity) that can be induced by platinum-based chemotherapy. The company, which was founded in 1996, previously operated under the name Adherex Technologies Inc. before officially rebranding as Fennec Pharmaceuticals Inc. in September 2014. Its corporate headquarters are situated in Research Triangle Park, North Carolina.
Harga Saham
$12.33
Terakhir disinkronkan: 2026-08-31
Kapitalisasi Pasar
$428.31M
Perubahan (1 hari)
0.49%
Perubahan (1 tahun)
39.01%
Negara
US
Perdagangan Fennec Pharmaceuticals Inc. (FENC)

Kategori

Healthcare
Riwayat hasil dividen untuk Fennec Pharmaceuticals Inc. (FENC)
Hasil dividen (TTM) dari Fennec Pharmaceuticals Inc. (simbol saham: FENC) per 2026: 0
Rata-rata hasil dividen selama 5 tahun terakhir: 0.00%
Riwayat hasil dividen untuk Fennec Pharmaceuticals Inc. (FENC) dari 2026 hingga 2026
Hasil dividen pada akhir setiap tahun (TTM)
Tahun Hasil Dividen Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Hasil dividen (TTM) untuk perusahaan serupa atau pesaing
Perusahaan Hasil Dividen Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH